While patients continue to benefit from increased product launches, the pandemic is still having an impact on caseload.
Mike Hollan
Advertisement
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Articles by Mike Hollan
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Launch is Just the Beginning: Rare Disease Care Requires Durability
2
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
3
Novartis to Layoff 322 NJ Employees: Report
4
FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma
5